Archive - September 2019
AbbVie/Allergan’s merger faces public opposition
Celgene’s ‘oral Vidaza’ clears phase 3 leukaemia trial
Vertex scores CF deal with Scotland, but access debate continues
Final chance to enter into the 2019 Communications Team of the Year & Marketer of the Year!
Roche preps filings for Herceptin/Perjeta combination
IQVIA and partners set up cancer ‘data hub’ to speed up research
National Security Heads Alarmed By China’s Control Of American Drug Supply
Prostate Cancer Signs And Symptoms That Indicate You Are At Risk